Fluid Guided Heart Failure Treatment at the Cleveland Clinic

ConditionHeart Failure
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorBodyport Inc.

About this trial

FIGHT-HF is an exploratory non-randomized open-label study evaluating a heart failure management intervention.

The goal of this pilot is to assess the performance of a fluid-guided heart failure management program and Alert Response Guide (ARG) using the Bodyport Cardiac Scale and Congestion Index in 50 adult participants with acute and chronic heart failure, who are followed by a Cleveland Clinic cardiologist.

Eligibility criteria

Qualifiers

Hospitalized for acute decompensated heart failure

Age 21 years or older

Able to speak and read English

Disqualifiers

New York Heart Association functional class IV symptoms

Received or are scheduled to receive a heart transplant or ventricular assist - device in the next 12 months

Have a glomerular filtration rate of less than 25 mL/min while nonresponsive to diuretic therapy or on chronic renal dialysis

Have a history of regularly scheduled intravenous HF therapy (e.g., inotropes or diuretics)

Trial design

Treatments tested in this trial

  • Heart Failure Management Intervention

Treatment groups

50 Participants
are divided into 1 treatment group

Sponsors and collaborators